Genetic polymorphisms in cytochrome P450 genes are associated with an increased risk of squamous cell carcinoma of the larynx and hypopharynx in a Chinese population

Cancer Genetics and Cytogenetics

Volumn 196, Issue 1, 2010, Pages 76-82

  Tai, Jun ^a   Yang, Ming ^b   Ni, Xin ^a   Yu, Dianke ^b   Fang, Jugao ^a   Tan, Wen ^b   Huang, Zhigang ^a   Wu, Chen ^b   Chen, Xiaohong ^a   Wang, Guanghai ^b   Zhou, Weiguo ^a   Chen, Xuejun ^a   Zhang, Wei ^a   Ma, Lijing ^a   Lin, Dongxin ^b   Han, Demin ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4;

ADULT; AGED; ARTICLE; CANCER RISK; CHINESE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; HYPOPHARYNX CARCINOMA; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SQUAMOUS CELL CARCINOMA;

ALLELES; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHINA; CYTOCHROME P-450 ENZYME SYSTEM; DNA PRIMERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNGEAL NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 71149107913     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.08.015     Document Type: Article

References (34)

1. Sankaranarayanan R., Masuyer E., Swaminathan R., Ferlay J., and Whelan S. Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res 18 (1998) 4779-4786
2. Nebert D.W., McKinnon R.A., and Puga A. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer. DNA Cell Biol 15 (1996) 273-280
3. Gonzalez F.J. The role of carcinogen-metabolizing enzyme polymorphisms in cancer susceptibility. Reprod Toxicol 11 (1997) 397-412
4. Shimada T., Yun C.H., Yamazaki H., Gautier J.C., Beaune P.H., and Guengerich F.P. Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens. Mol Pharmacol 41 (1992) 856-864
5. Wenzlaff A.S., Cote M.L., Bock C.H., Land S.J., Santer S.K., Schwartz D.R., and Schwartz A.G. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study. Carcinogenesis 26 (2005) 2207-2212
6. Noda N., Matsuzoe D., Konno T., Kawahara K., Yamashita Y., and Shirakusa T. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase μ1 polymorphisms. Oncol Rep 12 (2004) 773-779
7. Cosma G., Crofts F., Taioli E., Toniolo P., and Garte S. Relationship between genotype and function of the human CYP1A1 gene. J Toxicol Environ Health 40 (1993) 309-316
8. Crofts F., Taioli E., Trachman J., Cosma G.N., Currie D., Toniolo P., and Garte S.J. Functional significance of different human CYP1A1 genotypes. Carcinogenesis 15 (1994) 2961-2963
9. Schwarz D., Kisselev P., Cascorbi I., Schunck W.H., and Roots I. Differential metabolism of benzo[a]pyrene and benzo[ a]pyrene-7,8-dihydrodiol by human CYP1A1 variants. Carcinogenesis 22 (2001) 453-459
10. Landi M.T., Bertazzi P.A., Shields P.G., Clark G., Lucier G.W., Garte S.J., Cosma G., and Caporaso N.E. Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics 4 (1994) 242-246
11. Petersen D.D., McKinney C.E., Ikeya K., Smith H.H., Bale A.E., McBride O.W., and Nebert D.W. Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. Am J Hum Genet 48 (1991) 720-725
12. Stoilov I., Akarsu A.N., Alozie I., Child A., Barsoum-Homsy M., Turacli M.E., Or M., Lewis R.A., Ozdemir N., Brice G., Aktan S.G., Chevrette L., Coca-Prados M., and Sarfarazi M. Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1. Am J Hum Genet 62 (1998) 573-584
13. Bejjani B.A., Stockton D.W., Lewis R.A., Tomey K.F., Dueker D.K., Jabak M., Astle W.F., and Lupski J.R. Multiple CYP1B1 mutations and incomplete penetrance in an inbred population segregating primary congenital glaucoma suggest frequent de novo events and a dominant modifier locus. Hum Mol Genet 9 (2000) 367-374
14. Li D.N., Seidel A., Pritchard M.P., Wolf C.R., and Friedberg T. Polymorphisms in P450 CYP1B1 affect the conversion of estradiol to the potentially carcinogenic metabolite 4-hydroxyestradiol. Pharmacogenetics 10 (2000) 343-353
15. Watanabe J., Hayashi S., and Kawajiri K. Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5′-flanking region. J Biochem 116 (1994) 321-326
16. Patten C.J., Smith T.J., Friesen M.J., Tynes R.E., Yang C.S., and Murphy S.E. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N′-nitrosonornicotine α-hydroxylation by human liver microsomes. Carcinogenesis 18 (1997) 1623-1630
17. Lee S.J., and Goldstein J.A. Functionally defective or altered CYP3A4 and CYP3A5 single nucleotide polymorphisms and their detection with genotyping tests. Pharmacogenomics 6 (2005) 357-371
18. Varzim G., Monteiro E., Silva R.A., Fernandes J., and Lopes C. CYP1A1 and XRCC1 gene polymorphisms in SCC of the larynx. Eur J Cancer Prev 12 (2003) 495-499
19. Ko Y., Abel J., Harth V., Brode P., Antony C., Donat S., Fischer H.P., Ortiz-Pallardo M.E., Thier R., Sachinidis A., Vetter H., Bolt H.M., Herberhold C., and Bruning T. Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue. Cancer Res 61 (2001) 4398-4404
20. Singh A.P., Shah P.P., Mathur N., Buters J.T., Pant M.C., and Parmar D. Genetic polymorphisms in cytochrome P4501B1 and susceptibility to head and neck cancer. Mutat Res 639 (2008) 11-19
21. Neuhaus T., Ko Y.D., Lorenzen K., Fronhoffs S., Harth V., Brode P., Vetter H., Bolt H.M., Pesch B., and Bruning T. Association of cytochrome P450 2E1 polymorphisms and head and neck squamous cell cancer. Toxicol Lett 151 (2004) 273-282
22. Lei D., Pan X., Guo C., Luan X., Xu F., Zhang L., and Liu D. Genetic polymorphism of cytochrome P4501A1 and susceptibility to laryngeal carcinoma. [In Chinese]. Zhonghua Er Bi Yan Hou Ke Za Zhi 37 (2002) 373-376
23. In: Greene F.L., Page D.L., Fleming I.D., Fritz A.G., Balch C.M., Haller D.G., and Morrow M. (Eds). American Joint Committee on Cancer; American Cancer Society. American Joint Comittee on Cancer staging manual. 6th ed (2002), Springer-Verlag, Philadelphia
24. In: Travis W.D., Colby T.V., Corrin B., Shimosato Y., Brambilla E., and Sobin L.H. (Eds). Histological typing of lung and pleural tumors. 3rd ed. World Health Organization International Histological Classification of Tumours (1999), World Health Organization, Geneva
25. Blin N., and Stafford D.W. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res 3 (1976) 2303-2308
26. Brennan P. Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it?. Carcinogenesis 23 (2002) 381-387
27. Sun T., Gao Y., Tan W., Ma S., Zhang X., Wang Y., Zhang Q., Guo Y., Zhao D., Zeng C., and Lin D. Haplotypes in matrix metalloproteinase gene cluster on chromosome 11q22 contribute to the risk of lung cancer development and progression. Clin Cancer Res 12 (2006) 7009-7017
28. Sun T., Gao Y., Tan W., Ma S., Shi Y., Yao J., Guo Y., Yang M., Zhang X., Zhang Q., Zeng C., and Lin D. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet 39 (2007) 605-613
29. Ikeya K., Jaiswal A.K., Owens R.A., Jones J.E., Nebert D.W., and Kimura S. Human CYP1A2: sequence, gene structure, comparison with the mouse and rat orthologous gene, and differences in liver 1A2 mRNA expression. Mol Endocrinol 3 (1989) 1399-1408
30. Song N., Tan W., Xing D., and Lin D. CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China. Carcinogenesis 22 (2001) 11-16
31. Shen Y., Li D.K., Wu J., Zhang Z., and Gao E. Joint effects of the CYP1A1 MspI, ERα PvuII, and ERα XbaI polymorphisms on the risk of breast cancer: results from a population-based case-control study in Shanghai, China. Cancer Epidemiol Biomarkers Prev 15 (2006) 342-347
32. Chen K., Jin M.J., Fan C.H., Song L., Jiang Q.T., Yu W.P., Ma X.Y., and Yao K.Y. A case-control study on the association between genetic polymorphisms of metabolic enzymes and the risk of colorectal cancer [In Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi 26 (2005) 659-664
33. Li M., Guan T.Y., Li Y., and Na Y.Q. Polymorphisms of GSTM1 and CYP1A1 genes and their genetic susceptibility to prostate cancer in Chinese men. Chin Med J (Engl) 121 (2008) 305-308
34. Li L., Lin P., Deng Y.F., Zhu Z.L., and Lu H.H. Relationship between susceptibility and prognosis of laryngeal cancer and genetic polymorphisms in CYP1A1 and GSTM1 [In Chinese]. Zhonghua Er Bi Yan Hou Ke Za Zhi 39 (2004) 2-7